These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33371010)

  • 21. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
    Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
    Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.
    Goulart BH; Ramsey SD
    Oncologist; 2013; 18(8):941-6. PubMed ID: 23873718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model.
    Lu MT; Raghu VK; Mayrhofer T; Aerts HJWL; Hoffmann U
    Ann Intern Med; 2020 Nov; 173(9):704-713. PubMed ID: 32866413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.
    Guichet PL; Liu BY; Desai B; Surani Z; Cen SY; Lee C
    AJR Am J Roentgenol; 2018 Mar; 210(3):489-496. PubMed ID: 29166147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
    Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of lung cancer incidence on the low-dose computed tomography arm of the National Lung Screening Trial: A dynamic Bayesian network.
    Petousis P; Han SX; Aberle D; Bui AA
    Artif Intell Med; 2016 Sep; 72():42-55. PubMed ID: 27664507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline Results of the West London lung cancer screening pilot study - Impact of mobile scanners and dual risk model utilisation.
    Bartlett EC; Kemp SV; Ridge CA; Desai SR; Mirsadraee S; Morjaria JB; Shah PL; Popat S; Nicholson AG; Rice AJ; Jordan S; Begum S; Mani A; Derbyshire J; Morris K; Chen M; Peacock C; Addis J; Martins M; Kaye SB; Padley SPG; Devaraj A;
    Lung Cancer; 2020 Oct; 148():12-19. PubMed ID: 32771715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
    Fu M; Travier N; Martín-Sánchez JC; Martínez-Sánchez JM; Vidal C; Garcia M;
    PLoS One; 2018; 13(4):e0195441. PubMed ID: 29621354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selecting lung cancer screenees using risk prediction models-where do we go from here.
    Tammemägi MC
    Transl Lung Cancer Res; 2018 Jun; 7(3):243-253. PubMed ID: 30050763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
    Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
    Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
    Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
    Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term cancer risk associated with lung nodules observed on low-dose screening CT scans.
    Pinsky P; Gierada DS
    Lung Cancer; 2020 Jan; 139():179-184. PubMed ID: 31812129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality.
    Prosper AE; Inoue K; Brown K; Bui AAT; Aberle D; Hsu W
    JAMA Netw Open; 2021 Aug; 4(8):e2119629. PubMed ID: 34427681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.
    Li N; Tan F; Chen W; Dai M; Wang F; Shen S; Tang W; Li J; Yu Y; Cao W; Xu Y; Qin C; Zhao L; Zhu M; Guo L; Wu Z; Yang Z; Zheng Y; Chen H; Liu Y; Wei D; Dong D; Cao J; Zhang S; Yan S; Wang N; Du L; Shen H; Wu N; He J;
    Lancet Respir Med; 2022 Apr; 10(4):378-391. PubMed ID: 35276087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving selection criteria for lung cancer screening. The potential role of emphysema.
    Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to general medical checkup and cancer screening guidelines according to self-reported smoking status: Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012.
    Kim EY; Shim YS; Kim YS; Lee SP; Ko KD; Choi WJ
    PLoS One; 2019; 14(10):e0224224. PubMed ID: 31639166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organized Lung Cancer Screening Pilot: Informing a Province-Wide Program in Ontario, Canada.
    Darling GE; Tammemägi MC; Schmidt H; Buchanan DN; Leung Y; McGarry C; Rabeneck L
    Ann Thorac Surg; 2021 Jun; 111(6):1805-1811. PubMed ID: 33039364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
    Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
    Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overwhelming support among urban Irish COPD patients for lung cancer screening by low-dose CT scan.
    Pallin M; Walsh S; O'Driscoll MF; Murray C; Cahalane A; Brown L; Carter M; Mitchell P; McDonnell TJ; Butler MW
    Lung; 2012 Dec; 190(6):621-8. PubMed ID: 23064487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.